Equities

Ondine Biomedical Inc

OBI:LSE

Ondine Biomedical Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)6.38
  • Today's Change-0.125 / -1.92%
  • Shares traded2.10k
  • 1 Year change-25.00%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2024 14:42 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2.981330
Total Receivables, Net0.330.180.25
Total Inventory1.071.291.06
Prepaid expenses0.220.381.83
Other current assets, total0.160.15--
Total current assets4.751534
Property, plant & equipment, net0.951.400.60
Goodwill, net------
Intangibles, net----0
Long term investments------
Note receivable - long term------
Other long term assets0.040.040.04
Total assets5.731734
LIABILITIES
Accounts payable1.360.391.20
Accrued expenses1.753.162.08
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.380.360.15
Other current liabilities, total--00.50
Total current liabilities3.493.913.92
Total long term debt0.161.020.56
Total debt0.541.380.71
Deferred income tax------
Minority interest----0
Other liabilities, total------
Total liabilities3.654.934.48
SHAREHOLDERS EQUITY
Common stock240235235
Additional paid-in capital111111
Retained earnings (accumulated deficit)(248)(234)(216)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2.091230
Total liabilities & shareholders' equity5.731734
Total common shares outstanding227195195
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.